Humira

(Image: Getty/Evgeny_D)

FDA approves the entrance of two biosimilars

By Ben Hargreaves

US FDA gives approval to Samsung Bioepis’ Humira biosimilar and Pfizer’s Rituxan biosimilar, as the number of such medicines gaining entry onto the US market steadily increases.

(Image: Getty/Utah778)

AbbVie shares fall as Humira lawsuit ramps up

By Maggie Lynch

The California Department of Insurance has sued AbbVie for allegedly providing monetary gifts to health-care providers for prescribing its biologic, Humira.